Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Rationale: The pharmacological effects of antidepressants in modulating noradrenergic transmission as compared to serotonergic transmission in a rat model of Parkinson’s disease under chronic L-DOPA therapy are insufficiently explored. Objectives: The aim of the present study was to investigate the effect of the tricyclic antidepressant desipramine administered chronically alone or jointly with L-DOPA, on motor behavior and monoamine metabolism in selected brain structures of rats with the unilateral 6-OHDA lesion. Methods: The antiparkinsonian activities of L-DOPA and desipramine were assessed behaviorally using a rotation test and biochemically based on changes in the tissue concentrations of noradrenaline, dopamine and serotonin and their metabolites, evaluated separately for the ipsi- and contralateral motor (striatum, substantia nigra) and limbic (prefrontal cortex, hippocampus) structures of rat brain by HPLC method. Results: Desipramine administered alone did not induce rotational behavior, but in combination with L-DOPA, it increased the number of contralateral rotations more strongly than L-DOPA alone. Both L-DOPA and desipramine + L-DOPA significantly increased DA levels in the ipsilateral striatum, substantia nigra, prefrontal cortex and the ipsi- and contralateral hippocampus. The combined treatment also significantly increased noradrenaline content in the ipsi- and contralateral striatum, while L-DOPA alone decreased serotonin level on both sides of the hippocampus. Conclusions: The performed analysis of the level of monoamines and their metabolites in the selected brain structures suggests that co-modulation of noradrenergic and dopaminergic transmission in Parkinson’s disease by the combined therapy with desipramine + L-DOPA may have some positive implications for motor and psychiatric functions but further research is needed to exclude potential negative effects.

References Powered by Scopus

Staging of brain pathology related to sporadic Parkinson's disease

8406Citations
N/AReaders
Get full text

Parkinson's disease: Clinical features and diagnosis

4176Citations
N/AReaders
Get full text

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

2325Citations
N/AReaders
Get full text

Cited by Powered by Scopus

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease

5Citations
N/AReaders
Get full text

Gastrointestinal dysmotility in rodent models of Parkinson’s disease

2Citations
N/AReaders
Get full text

Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kamińska, K., Lenda, T., Konieczny, J., & Lorenc-Koci, E. (2022). Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease. Psychopharmacology, 239(11), 3633–3656. https://doi.org/10.1007/s00213-022-06238-x

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

33%

Researcher 2

33%

Lecturer / Post doc 1

17%

PhD / Post grad / Masters / Doc 1

17%

Readers' Discipline

Tooltip

Neuroscience 2

33%

Agricultural and Biological Sciences 2

33%

Nursing and Health Professions 1

17%

Sports and Recreations 1

17%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free